Studies have shown a positive association between increased CD8+ CTLs in the tumor microenvironment and better prognosis in cancer patients, including but not limited to cervical cancer patients, breast cancer patients, and colorectal cancer patients [30–32]. This evidence concerns the gene CD8A and cervical carcinoma.